|
|
|
|
|
Session 10
Oral Abstracts Complications of Antiretroviral Therapy Wednesday, 10 am - 12:30 pm Presentation Time: 11:00 am Auditorium |
Background: Prior data from the D:A:D
Study suggest association of combined ART exposure
with an increased risk of myocardial infarction. We investigated if the linear
trend previously reported continues with further combined ART exposure, whether
it is modified by age or sex, and possible mechanisms for this relationship. Methods: Observational study of 23,441 HIV-infected
patients (24% women) from 11 cohorts from Europe, Australia, and the United
States were followed to February 2004 to determine the incidence rates of first
prospective myocardial infarction (per 1000 person-years), and relative rates
of factors associated with myocardial infarction from Poisson
regression models are reported. Results: By 2004, the mean exposure time to combined ART
was
4.46 years. Over 76,577 patient-years, 277 patients
experienced a first myocardial infarction. The
myocardial infarction incidence
increased from 1.39/1000 patient-years in those not exposed to combined ART, to
2.53/1000 patient-years in those exposed for < 1 year, to 6.07/1000 patient-years
in those exposed for ≥ 6 years (RR compared to no exposure: 4.38 [95% CI 2.39 to 8.04], p = 0.0001). After adjustment for other
potential risk factors, there was a 1.17-fold [1.11 to 1.24] increased risk of myocardial
infarction per additional year of combined ART exposure. Similar results were
found after inclusion of repeat myocardial infarctions (1.18 [1.09 to 1.28]),
inclusion of only definite myocardial infarction (58.5% of myocardial
infarctions) (1.22 [1.11 to 1.35]), and restricting the analysis to naïve
patients (n = 4161) at entry (1.39 [0.93 to 2.08]). Although the rate of myocardial
infarction was higher in men than women (2.04 [1.30 to 3.21]), the RR
associated with combined ART was similar in men (1.14 [1.06 to 1.24]) and women
(1.38 [1.07 to 1.76], p value for
interaction 0.51). The relationship was similar in younger and older patients
(men > 45 and women > 55 years; p
value for interaction 0.41). Including time-updated levels of serum total
cholesterol (RR 1.15 [1.06 to 1.25] per mmol/L), HDL
cholesterol (0.60 [0.42 to 0.88] per mmol/L), and
triglycerides (1.64 [0.98 to 2.74] per log2) in the same model,
reduced the association of additional year of combined ART with myocardial
infarction to 1.10 [1.01 to 1.19]. Adjustment for lipid-lowering medication did
not further affect the association between combined ART exposure and myocardial
infarction. Lipodystrophy was not associated with the
risk of myocardial infarction (RR 0.99 [0.75 to 1.30]). Conclusions: These findings suggest that while the overall
absolute risk of myocardial infarction remains modest, the risk
continues to increase with longer exposure to combined ART over the first 7 years
of use. The relative increase in risk appears similar in men and women, and in
older and younger subjects. Dyslipidemia explained
part but not all of the association of combined ART with risk of myocardial
infarction. Keywords: adverse effects; myocardial infarction; cardiovascular disease
|